\nPresentation \nVectra 8 mg tablet: Each tablet contains Betahistine Hydrochloride USP 8 mg. \nVectra 16 mg tablet: Each tablet contains Betahistine Hydrochloride USP 16 mg. \n \nIndication \nBetahistine is indicated for treatment of Meniere?s syndrome, symptoms of which may include vertigo, tinnitus, hearing loss and nausea. \n \nSupply \nVectra 8 mg tablet: Each box contains 5x10?s tablets in Alu-Alu blister pack. \nVectra 16 mg tablet: Each box contains 5x10?s tablets in Alu-Alu blister pack.